Neurovine Valuation Estimate
Neurovine Valuation as of Last Funding Round
Neurovine Company Overview
Neurovine.ai is a company that offers cognitive pacing solutions aimed at improving cognitive performance and mental health. The company provides an EEG Sensorband that connects with cloud-based analytic software to deliver real-time brain energy monitoring and notifications when rest is needed. Users can monitor their mental health, increase productivity, enhance resiliency, and improve cognitive performance with 24/7 access to their brain data through a mobile app. Neurovine.ai is involved in ongoing research studies to understand the benefits of its technology in the field of brain health
Neurovine Valuation History
Neurovine Stock Price
The stock price of Neurovine can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Neurovine has issued 250 million shares, at the estimated UpMarket valuation of $9.82 million, each share of Neurovine stock would be worth $0.04.
Buy Neurovine Stock
If you would like to buy shares in Neurovine, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Neurovine stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Neurovine as well.
Neurovine Management
| Name | Position |
|---|---|
| Ashleigh Kennedy | CEO |
| Patrick Leckey | CTO |
